# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4030009 | A | Unbound fraction in guinea pig plasma at 3 mg/kg administered as iv infusion | Cavia porcellus | 1 | ALA4028831 | organism-based format | Scientific Literature | |
2. | ALA4030010 | B | Inhibition of Nav1.5 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
3. | ALA4030011 | B | Inhibition of human ROMK channel expressed in HEK293 cells after 30 mins by FLIPR based thallium flux assay | Homo sapiens | 47 | ALA4028831 | cell-based format | Scientific Literature | |
4. | ALA4030012 | B | Displacement of [35S]MK499 from human ERG expressed in HEK293 cells | Homo sapiens | 47 | ALA4028831 | cell-based format | Scientific Literature | |
5. | ALA4030013 | B | Selectivity ratio of IC50 for human ERG expressed in HEK293 cells to IC50 for human ROMK expressed in HEK293 cells | Homo sapiens | 37 | ALA4028831 | cell-based format | Scientific Literature | |
6. | ALA4030020 | F | Antihypertensive activity in rat spontaneous hypertensive model assessed as change in systolic blood pressure at 3 mg/kg, po qd measured after 3 days | Rattus norvegicus | 5 | ALA4028831 | organism-based format | Scientific Literature | |
7. | ALA4030027 | A | Clearance in Wistar Han rat at 1 mg/kg, iv or 2 mg/kg, po | Rattus norvegicus | 2 | ALA4028831 | organism-based format | Scientific Literature | |
8. | ALA4030028 | A | Volume of distribution at steady state in Wistar Han rat at 1 mg/kg, iv or 2 mg/kg, po | Rattus norvegicus | 2 | ALA4028831 | organism-based format | Scientific Literature | |
9. | ALA4030029 | A | Dose normalized AUC in Wistar Han rat at 2 mg/kg, po | Rattus norvegicus | 2 | ALA4028831 | organism-based format | Scientific Literature | |
10. | ALA4030030 | A | Half life in Wistar Han rat at 1 mg/kg, iv or 2 mg/kg, po | Rattus norvegicus | 2 | ALA4028831 | organism-based format | Scientific Literature | |
11. | ALA4030031 | A | Oral bioavailability in Wistar Han rat at 2 mg/kg | Rattus norvegicus | 2 | ALA4028831 | organism-based format | Scientific Literature | |
12. | ALA4030032 | B | Inhibition of human ROMK expressed in CHO cells at -70 mV holding potential after 6 mins by whole cell patch clamp Qpatch method | Homo sapiens | 8 | ALA4028831 | cell-based format | Scientific Literature | |
13. | ALA4030033 | B | Inhibition of human ERG by Qpatch electrophysiology method | Homo sapiens | 8 | ALA4028831 | single protein format | Scientific Literature | |
14. | ALA4030034 | B | Selectivity ratio of IC50 for human ERG to IC50 for human ROMK expressed in CHO cells | Homo sapiens | 8 | ALA4028831 | cell-based format | Scientific Literature | |
15. | ALA4030035 | B | Inhibition of Kir2.1 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
16. | ALA4030036 | B | Inhibition of Cav1.2 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
17. | ALA4030037 | A | Inhibition of CYP3A4 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
18. | ALA4030038 | A | Inhibition of CYP2D6 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
19. | ALA4030039 | A | Inhibition of CYP2C9 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature | |
20. | ALA4030040 | A | Inhibition of CYP2C8 (unknown origin) | Homo sapiens | 1 | ALA4028831 | single protein format | Scientific Literature |